All Industries

Top Life Sciences Companies

416 Life Sciences companies, sorted by total funding raised.

Motif FoodWorksClosed

Motif FoodWorks is a synthetic biology company that designs and sells ingredients to companies th...

Boston, United States11–50Life Sciences
Series B·$343.5M·Jun 2021
MEGAROBO

AI-powered robotics platform for laboratory automation, life sciences, and smart manufacturing in...

Beijing, China201–500Robotics, Life Sciences
Series C·$342.3M·Jun 2022
Redesign Health

Venture and applied-technology firm that builds and funds healthcare startups, partnering with fo...

New York, United States51–200Life Sciences, Artificial Intelligence
Venture Round·$340.0M·Dec 2024
Seaport Therapeutics

Seaport Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric me...

Boston, United States11–50Life Sciences
Grant·$340.0M·Mar 2026
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Corporate Round·$335.0M·Dec 2024
Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...

Belmont, United States11–50Life Sciences, Biotech
Series B·$321.0M·Nov 2025
Zenas BioPharmaIPO

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...

Boston, United States51–200Biotech, Healthcare
Series C·$318.0M·May 2024
ArriVentIPO

Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...

Newtown Square, United States11–50Biotech, Healthcare
Series B·$305.0M·Mar 2023
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$304.5M·Mar 2025
Valo Health

AI-enabled biotechnology company using large-scale human data and computation to accelerate drug ...

Boston, United States51–200Artificial Intelligence, Biotech
Series B·$300.0M·Mar 2021
BenchSci

AI-powered platform that accelerates drug discovery by helping pharmaceutical researchers find th...

Toronto, Canada201–500Artificial Intelligence, Drug Discovery
Series D·$265.2M·May 2023
FibroGenIPO

Develops novel therapeutics in oncology and anemia, advancing antibody-drug conjugates and HIF-PH...

San Francisco, United States11–50Biotech, Life Sciences
Venture Round·$261.5M·Nov 2022
Kronos BioAcquired

Clinical-stage biopharma developing small‑molecule therapeutics targeting deregulated transcripti...

San Mateo, United States1–10Biotech, Healthcare
Series B·$260.0M·Aug 2020
Harbor Health

Austin-based primary and specialty clinic group that provides integrated care and clinician-desig...

Austin, United States201–500Life Sciences, Healthcare
Series B·$258.0M·Sep 2025
Frontier Medicines

Clinical-stage precision-medicine biotech using chemoproteomics and AI to discover covalent small...

San Francisco, United States51–200Biotech, Drug Discovery
Extension Round·$255.5M·Jun 2024
SonderMind

Technology-driven behavioral health platform connecting individuals with therapists and mental he...

Denver, United States201–500Healthcare, Life Sciences
Venture Round·$255.0M·Jan 2025
PathAI

PathAI is a leading provider of AI-powered research tools and services for pathology.

Boston, United States201–500Artificial Intelligence, Biotech
Series C·$251.0M·May 2021
Alpha-9 Oncology

Clinical-stage radiopharmaceutical company developing differentiated and highly targeted radiopha...

Vancouver, CanadaLife Sciences, Biotech
Series C·$250.1M·Oct 2024
Vir BiotechnologyIPO

Clinical-stage biotech developing antibody- and T-cell engager-based therapeutics for infectious ...

San Francisco, United States201–500Biotech, Drug Discovery
Growth Equity·$250.0M·Oct 2024
InventisBioIPO

Clinical-stage biopharmaceutical company developing small-molecule therapies for oncology, autoim...

Shanghai, China11–50Biotech, Life Sciences
Series D·$247.0M·Sep 2020
Agios PharmaceuticalsIPO

Commercial-stage biopharmaceutical company developing therapies for rare hematologic diseases by ...

Cambridge, United States501–1000Biotech, Drug Discovery
Series C·$241.0M·Nov 2011
Cadence

AI-powered remote patient monitoring platform delivering chronic disease management to patients a...

New York, United States201–500Life Sciences
Series C·$241.0M·Jun 2026
Elligo Health Research

Connecting life sciences companies with physicians, patients, and data to accelerate clinical tri...

Austin, United States201–500Biotech, Healthcare
Series E·$236.0M·Sep 2021
Truvian

Develops an automated benchtop blood-testing analyzer that delivers lab-accurate routine blood te...

San Diego, United States51–200Life Sciences, Diagnostics
Growth Equity·$225.3M·Jul 2024
PB Health

PB Health is a comprehensive healthcare delivery platform comprising network of hospitals, preven...

Gurugram, India51–200Life Sciences, Healthcare
Seed·$218.0M·May 2025